Morphine for refractory breathlessness in COPD: a randomized clinical intervention study Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD Year: 2020
Placebo-controlled, double-blind trial of chronic, intermittent ‘pulse‘ therapy of moxifloxacin to prevent acute exacerbations in COPD patients with chronic bronchitis: baseline data Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients Year: 2006
Efficacy and safety of sequential three-step empirical therapy for chronic cough: a multi-center clinical study Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017
Can we predict response of refractory asthmatic cough to tiotropium? :a prospective study Source: Virtual Congress 2020 – Chronic cough: only symptom or disease? Year: 2020
Comparison of two physiotherapy treatments in patients with acute exacerbation of chronic obstructive pulmonary disease: a pilot study Source: Virtual Congress 2021 – A multidisciplinary approach to pulmonary rehabilitation and management of chronic respiratory diseases Year: 2021
Acute exacerbations of chronic bronchitis managed in primary care in tunisia: a prospective transversal study of more than 1,561 outpatients Source: Annual Congress 2009 - Quality of treatment in primary respiratory care Year: 2009
Is chronic breathlessness less recognised and treated compared with chronic pain? A case-based randomised controlled trial Source: Eur Respir J, 52 (3) 1800887; 10.1183/13993003.00887-2018 Year: 2018
Benefits of interferon-αcon-1 (IFN-αcon-1) as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy. Results of a 12-month prospective case-controlled study Source: Eur Respir J 2006; 28: Suppl. 50, 439s Year: 2006
Neomacrolides in the treatment of patients with severe asthma and/or bronchiectasis: A retrospective observational study Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010
Efficacy of antifibrotics in chronic hypersensitivity pneumonitis. A 3 year real-life observational study Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment Year: 2020
Nonpharmacological cough control therapy for chronic refractory cough and cough associated with underlying lung disease Source: ERJ Open Res, 6 (1) 00243-2019; 10.1183/23120541.00243-2019 Year: 2020
Chronic cough: objective cough frequency in a large cough clinic cohort Source: International Congress 2017 – Notable abstracts in asthma Year: 2017
How to manage chronic cough patients Source: ERS Satellites 2021 Year: 2021
Treatment approach in chronic dry cough patients Source: Annual Congress 2010 - Airway responsiveness, chronic cough and bronchiectasis: a modern approach Year: 2010
Opioid prescription for severe chronic breathlessness to hospitalised patients with COPD - a clinical audit Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020
Does automated oxygen control with O2matic reduce frequency and duration of hypoxemic episodes in patients admitted with exacerbation of COPD? – a randomized controlled trial Source: International Congress 2019 – Airway physiology Year: 2019
An open-label study of the tolerability and potential efficacy of memantine for treating refractory chronic cough Source: ERJ Open Res, 7 (3) 00447-2021; 10.1183/23120541.00447-2021 Year: 2021
A single centre double-blind placebo controlled pilot study into the use of intravenous magnesium sulphate for the treatment of acute exacerbation of chronic obstructive airways disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 343s Year: 2004
Withdrawal of inhaled corticosteroids in people with chronic obstructive pulmonary disease (COPD) in primary care – a randomised controlled trial Source: Annual Congress 2005 - Effects of anti-inflammatory drugs on COPD Year: 2005
A clinical and outcomes assessment of the management of acute episodes of chronic bronchitis (AECB) : the MOSAIC study - baseline characteristics of screened patients Source: Eur Respir J 2002; 20: Suppl. 38, 544s Year: 2002